AI-generated summary
This review describes laser technologies, including fractional and non-fractional lasers, as tools to enhance skin vaccination. The authors report that laser illumination can augment vaccine-induced immune responses without significant local or systemic side effects, and that lasers may also aid needle-free transcutaneous vaccine delivery. They note that clinical studies are still needed.
- Limits stated in the abstract
- The abstract does not report a sample size or specific study data, and it states that skin vaccine delivery and adjuvant safety remain largely undefined and need clinical testing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.